Minimal Optimal Dose of Sugammadex in Elective Surgery

• Status: Completed
• Trial end date: 2018-09-30
• Target enrollment: 0
• Participant gender: All

Summary

Time of appearance of TOF Ratio >0,9 with different doses of Sugammadex

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Erasme University Hospital

Criteria

Inclusion Criteria:

women and men> 18 years of age Elective Surgery BMI <30, patients who gave consent to free and informed participation in writing

Exclusion Criteria:

• minor patients;

• patients refusing to sign consent;

• patients included in another protocol within 3 months;

• pregnant or nursing patients;

• patients with a history of allergy to Sugammadex;

• patients with known neuromuscular disease

• patients with renal or hepatic impairment.